Sage Therapeutics(SAGE) - 2024 Q1 - Earnings Call Presentation

First Quarter 2024 Financial Results April 25, 2024 Safe Harbor Statement and cost of clinical trials or development efforts and ourability to proceed with further development. • The slides presentedtodayand the accompanying oral presentations contain forward-lookingstatements, – Even if our other product candidates are successfully developed and approved, the number ofpatients with which may be identifiedby the use ofwords such as “may,” “might,” “will,” “should,”“can,” “expect,” “plan,” the diseases or di ...